We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Surgery May Be the Best Option for Severe Migraine Headaches

By HospiMedica International staff writers
Posted on 04 Nov 2009
A new study shows that treating migraine trigger sites by local surgery could potentially cure migraine headaches.

Researchers at Case Western Reserve University School of Medicine (CSR, Cleveland, OH, USA) followed 79 migraine sufferers for at least five years, after having undergone detection of migraine "trigger sites" and subsequent surgery. More...
Since the surgery, 10 of the 79 patients required additional surgeries for newly detected trigger sites and were eliminated from the final analysis. Sixty-one of the remaining 69 patients (88%) maintained the initial positive response to the surgery. Twenty patients (29%) reported elimination of migraines entirely, 41 patients (59%) noticed a significant decrease, and only eight patients (11%) experienced less than 50% improvement or no change. The study was presented at the American Society of Plastic Surgeons annual meeting, held during October 2009 in Seattle (WA, USA).

"Migraine headaches are extremely disabling and this surgical option offers hope for migraine sufferers,” said study presenter Bahman Guyuron, M.D., chairman of the plastic surgery department at CSR. "Combined with the previous studies, this new five-year data has provided strong evidence that severe migraine headaches and their painful symptoms can be successfully treated with surgery with lasting results.”

The surgical procedure involves removal of the muscle groups that are suspected of being a trigger point for headaches by compressing nerves and causing nerve inflammation. For frontal migraine headaches, this involves the corrugator supercilii (frowning) muscle group in the forehead. Temple migraine headaches are treated by removing a small branch of the trigeminal nerve. For those patients who suffer from occipital (back of the head) migraine headaches, a small piece of muscle encasing the nerve is removed and replace with a soft tissue flap. When the headaches are located behind eyes and are triggered by weather change, the nose septum and surrounding structures are treated.

Related Links:
Case Western Reserve University School of Medicine



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Emergency Ventilator
Shangrila935
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.